Docusign Inc (NASDAQ:DOCU) CRO Loren Alhadeff sold 32,000 shares of the stock in a transaction on Friday, December 6th. The stock was sold at an average price of $75.00, for a total value of $2,400,000.00. Following the completion of the sale, the executive now owns 238,078 shares in the company, valued at approximately $17,855,850. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Loren Alhadeff also recently made the following trade(s):
- On Wednesday, December 4th, Loren Alhadeff sold 8,000 shares of Docusign stock. The shares were sold at an average price of $69.76, for a total value of $558,080.00.
- On Monday, October 7th, Loren Alhadeff sold 11,400 shares of Docusign stock. The stock was sold at an average price of $67.98, for a total value of $774,972.00.
- On Friday, September 20th, Loren Alhadeff sold 4,600 shares of Docusign stock. The stock was sold at an average price of $65.01, for a total value of $299,046.00.
- On Tuesday, September 17th, Loren Alhadeff sold 10,821 shares of Docusign stock. The stock was sold at an average price of $61.79, for a total value of $668,629.59.
Shares of DOCU stock opened at $72.79 on Wednesday. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 1.06. The business has a 50-day moving average price of $68.63 and a two-hundred day moving average price of $57.56. Docusign Inc has a 12-month low of $36.25 and a 12-month high of $76.28. The firm has a market cap of $13.28 billion, a P/E ratio of -25.10 and a beta of 1.46.
Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, December 5th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.08. The firm had revenue of $249.50 million during the quarter, compared to analysts’ expectations of $240.40 million. Docusign had a negative return on equity of 26.51% and a negative net margin of 25.28%. Docusign’s revenue was up 39.9% compared to the same quarter last year. As a group, research analysts expect that Docusign Inc will post -1.04 EPS for the current fiscal year.
Several analysts have weighed in on DOCU shares. Evercore ISI began coverage on Docusign in a report on Monday, November 4th. They issued an “outperform” rating and a $80.00 price target on the stock. Royal Bank of Canada boosted their price objective on Docusign from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. JMP Securities upped their price objective on shares of Docusign to $86.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Deutsche Bank upped their price objective on shares of Docusign from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Finally, Zacks Investment Research raised shares of Docusign from a “sell” rating to a “hold” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Docusign has an average rating of “Buy” and an average target price of $74.75.
Large investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its stake in Docusign by 58.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 16,338,342 shares of the company’s stock worth $812,179,000 after acquiring an additional 6,051,597 shares during the last quarter. BlackRock Inc. raised its stake in shares of Docusign by 98.2% during the 2nd quarter. BlackRock Inc. now owns 5,122,761 shares of the company’s stock worth $254,654,000 after buying an additional 2,537,764 shares during the period. Jericho Capital Asset Management L.P. acquired a new position in shares of Docusign during the 3rd quarter worth approximately $77,119,000. Scout Investments Inc. purchased a new position in shares of Docusign during the 3rd quarter valued at approximately $67,705,000. Finally, Morgan Stanley lifted its holdings in Docusign by 73.7% during the second quarter. Morgan Stanley now owns 2,440,441 shares of the company’s stock valued at $121,314,000 after purchasing an additional 1,035,506 shares in the last quarter. Institutional investors own 81.66% of the company’s stock.
Docusign Company Profile
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Featured Article: How can investors benefit from after-hours trading?
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.